Fish and the Thyroid: A Janus Bifrons Relationship Caused by Pollutants and the Omega-3 Polyunsaturated Fatty Acids
- 1Department for Life Quality Studies, Alma Mater Studiorum, University of Bologna, Rimini, Italy
- 2Department of Human Pathology and Childhood “G. Barresi” (DETEV), University of Messina, Messina, Italy
A commentary on
Fish and the thyroid: A Janus Bifrons relationship caused by pollutants and the omega-3 polyunsaturated fatty acids
By Benvenga S, Famà F, Perdichizzi LG, Antonelli A, Brenta G, Vermiglio F and Moleti M (2022) Front. Endocrinol. 13:891233. doi: 10.3389/fendo.2022.891233
Introduction
We read with interest the paper published in the journal by Benvenga S, et al. (1) about the complex interplay between thyroid disorders and the intake of omega-3 polyunsaturated fatty acids (PUFAs), whose main dietary source is represented by fish. In their review, Benvenga et al. (1) put a specific warning on the potential heavy metal content in fish and the risks deriving from its consumption, suggesting that there would be the place for the use of nutraceuticals containing omega-3 PUFAs to prevent or contrast autoimmune thyroiditis, overcoming the risk of contaminants in fish. Although pharmacological supplementation would be sometimes useful, also limiting dietary consumption to fishes containing low levels of pollutants and including fish within the framework of a healthy diet represent a good choice.
Fish: Friend or foe?
Benvenga et al. elaborate on the adverse health effects of consuming fish containing high heavy metal levels, although they also state that most consumed fish is generally safe. Indeed, heavy metals, particularly mercury (Hg), are mostly concentrated in large predatory fishes, but their content in small fishes, like anchovy and sardine, is generally low (1). These small oily fishes (the so-called “pesce azzurro”) represent the most frequently consumed fishes in the Mediterranean diet, and their consumption is associated with the lowest risk of contamination and the higher intake of PUFAs, as the authors themselves emphasized (1). Moreover, the European Union establishes that the maximum Hg quantity in fish sold in Europe must be equal to 0.5 mg/kg of edible product (2). Salmon, anchovies, sardines, and trout contain Hg levels far from this limit. Hence, the risk of adverse effects of Hg is substantially low, strictly depending on the type of fish (3). Thus, a moderate consumption of oily fishes should be considered safe and healthy; accordingly, fish consumption is recommended twice a week in order to provide 250 mg/day of omega-3 acids [EPA + Docosahexaenoic acid (DHA)] (4). The fragmented information that consumers receive about the nutritional value and health risks associated with fish can result in confusion or misperceptions about these food sources. However, as clearly stated by Mozaffarian and Rimm (5), the benefits of fish intake largely exceed the potential risks, with the exception of a few selected species in sensitive populations.
Fish vs. polyunsaturated fatty acid nutritional supplements
There is an argument to be made that fish has been considered a better choice than supplementation in the form of nutraceuticals in the treatment of chronic degenerative diseases. Dietary fish intake is associated with a reduction in fatal cardiovascular disease (CVD) events in a threshold manner, with a benefit seen with approximately two servings per week of fish (6), whereas multiple randomized studies and meta-analysis showed inconsistent effects on the reduction of CVD risk with low- or high-dose PUFA supplementation in people at high risk of CVD, with many studies demonstrating no evidence of benefit (7–9). In an interesting review, Petsini et al. collected and compared the existing fish intervention trials in healthy volunteers with the aim to examine the effect of either fish intake or the consumption of omega-3 fatty acids via capsules on biomarkers related to CVD. They concluded that not only do fish oil supplements have a beneficial effect on several CVD biomarkers but also fish consumption gives promising results, affecting CVD and inflammatory and thrombotic biomarkers, despite differences between studies and challenges in conducting/comparing dietary and supplement intervention trials (10). Indeed, the ingredients of fish flesh other than PUFAs may also contribute to the beneficial effect of its consumption, such as amino acids, trace elements, and other micronutrients, suggesting that the food in its complexity has a protective role (11–15). This point has also been stated by Jacobs et al., proposing that ‘‘thinking food first’’ results in more effective nutrition research and policy (16). Although Benvenga et al. (1) did not neglect the difference between fish consumption and omega-3 PUFA supplementation, we would like to further emphasize the importance of the whole nutritional composition of fish, which could not be simply reduced to PUFA content. However, not everyone is a seafood fan, and nutraceuticals could be a good choice in people who do not like fish, have a fish allergy, or are vegetarian, for instance.
Fish consumption in the framework of Mediterranean diet
Undoubtedly, fish consumption should be more studied in regard to its effect on chronic inflammatory and immune-mediated disorders, including autoimmune thyroiditis, and the balance between “costs” (i.e., contaminants) and benefits (healthy components) should be carefully evaluated. Moreover, fish influence should be included in a complete healthy dietary plan, including fish with low Hg content, as patients would be benefited both from fish intake and other micronutrients and nutraceuticals. In this light, the Mediterranean diet may represent a healthy nutritional model. Indeed, fish (namely, the blue one rich in omega-3) is a cornerstone of the Mediterranean diet (17). This dietary regimen is characterized by a high intake of vegetables, legumes, fresh fruits, nuts, whole grains, and olive oil; frequent and moderate consumption of red wine; moderate intake of seafood (two times a week, preferably choosing small oily fishes), dairy products, poultry, and eggs; and a low consumption of red meat and processed meat products. Due to the synergistic effects of its many ingredients, the Mediterranean diet exerts anti-inflammatory, immunomodulatory, and antioxidant effects, which are also beneficial to the health status in the setting of autoimmune thyroiditis (18). Thus, in our opinion, fish consumption must be considered in the frame of the Mediterranean diet, and the importance of a healthy diet should not be overlooked.
Conclusion
In conclusion, supplements represent a useful way to get nutrients otherwise lacking in selected populations and specific periods of life, but they cannot replicate all of the nutrients and benefits of whole foods and are not intended to replace a healthy diet. Tailored dietary interventions should represent a useful lifestyle strategy for preventing or counteracting the autoimmune inflammation of the thyroid gland in the long run. Obviously much research is still needed, but we believe that is possible to suggest that an optimal consumption of fish as part of a Mediterranean diet plan represents the best preventive or protective strategy against many chronic or degenerative diseases, including autoimmune thyroid diseases.
Author contributions
HS and RMR wrote the first draft of the manuscript. MCB and CS contributed to manuscript revision. All authors read and approved the submitted version.
Funding
This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Benvenga S, Famà F, Perdichizzi LG, Antonelli A, Brenta G, Vermiglio F, et al. Fish and the thyroid: A janus bifrons relationship caused by pollutants and the omega-3 polyunsaturated fatty acids. Front Endocrinol (2022) 13:891233. doi: 10.3389/fendo.2022.891233
2. European Union. EU Community directive on chemical contaminants in foodstuffs [16 commission regulation (EC) no. 221/2002]. Brussels: EU (2002).
3. EFSA (European Food Safety Authority). Statement on the benefits of fish/seafood consumption compared to the risks of methylmercury in fish/seafood. ESFA J 3 (2015) 13(1):3982.
4. Persson M, Fagt S, Nauta MJ. Optimising healthy and safe fish intake recommendations: A trade-off between personal preference and cost. Br J Nutr (2019) 122:206–19. doi: 10.1017/S0007114519000989
5. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA (2006) 296(15):1885–99. doi: 10.1001/jama.296.15.1885
6. Albert CM, Hennekens CH, O’Donnell CJ, Ajani UA, Carey VJ, Willett WC, et al. Fish consumption and risk of sudden cardiac death. JAMA (1998) 279(1):23–8. doi: 10.1001/jama.279.1.23
7. Aung T, Halsey J, Kromhout D, Gerstein HC, Marchioli R, Tavazzi L, et al. Associations of omega-3 fatty acid supplement use with cardiovascular disease risks. meta-analysis of 10 trials involving 77,917 individuals. JAMA Cardiol (2018) 3:225–34. doi: 10.1001/jamacardio.2017.5205
8. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA (2012) 308:1024–33. doi: 10.1001/2012.jama.11374
9. Haq A, White S, Miedema MD. Fish intake, fish oil, and cardiovascular health – is it better to just eat the real thing? America Coll Cardiol Expert Anal (2021). https://www.acc.org/latest-in-cardiology/articles/2021/11/01/12/41/fish-intake-fish-oil-and-cardiovascular-health
10. Petsini F, Fragopoulou E, Antonopoulou S. Fish consumption and cardiovascular disease related biomarkers: A review of clinical trials. Crit Rev Food Sci Nutr (2019) 59:2061–71. doi: 10.1080/10408398.2018.1437388
11. Elvevoll EO, Eilertsen KE, Brox J, Dragnes BT, Falkenberg P, Olsen JO, et al. Seafood diets: hypolipidemic and antiatherogenic effects of taurine and n-3 fatty acids. Atherosclerosis (2008) 200(2):396–402. doi: 10.1016/j.atherosclerosis.2007.12.021
12. Aadland EK, Lavigne C, Graff IE, Eng O, Paquette M, Holthe A, et al. Lean-seafood intake reduces cardiovascular lipid risk factors in healthy subjects: Results from a randomized controlled trial with a crossover design. Am J Clin Nutr (2015) 102:582–92. doi: 10.3945/ajcn.115.112086
13. Yamori Y, Taguchi T, Mori H, Mori M. Low cardiovascular risks in the middle aged males and females excreting greater 24-hour urinary taurine and magnesium in 41 WHO-CARDIAC study populations in the world. J Biomed Sci (2010) 17(Suppl. 1):S21. doi: 10.1186/1423-0127-17-S1-S21
14. Maehre H, Jensen IJ, Elvevoll E, Eilertsen KE. V-3 fatty acids and cardiovascular diseases: Effects, mechanisms and dietary relevance. Int J Mol Sci (2015) 16:22636–61. doi: 10.3390/ijms160922636
15. Tørris C, Småstuen MC, Molin M. Nutrients in fish and possible associations with cardiovascular disease risk factors in metabolic syndrome. Nutrients (2018) 10:952. doi: 10.3390/nu10070952
16. Jacobs D, Gross MD, Tapsell LC. Food synergy: an operational concept for understanding nutrition. Am J Clin Nutr (2009) 89(suppl):1543S–8S. doi: 10.3945/ajcn.2009.26736B
17. Molina-Vega M, Gómez-Pérez AM, Tinahones FJ. Fish in the Mediterranean diet. In: Preedy VR, Watson RR, editors. The Mediterranean diet, 2nd ed. Academic Press (2020). p. 275–84.
Keywords: fish, Mediterranean diet, autoimmunity, endocrine disruptors, PUFA - polyunsaturated fatty acids, nutraceuticals
Citation: Hrelia S, Barbalace MC, Cannavò S and Ruggeri RM (2023) Commentary: Fish and the thyroid: A Janus Bifrons relationship caused by pollutants and the omega-3 polyunsaturated fatty acids. Front. Endocrinol. 14:1138245. doi: 10.3389/fendo.2023.1138245
Received: 05 January 2023; Accepted: 22 March 2023;
Published: 11 April 2023.
Edited by:
Caterina Mian, University of Padua, ItalyReviewed by:
Samantha D Pauls, University of Manitoba, CanadaEsmail Lutfi, Norwegian Institute of Food, Fisheries and Aquaculture Research (Nofima), Norway
Copyright © 2023 Hrelia, Barbalace, Cannavò and Ruggeri. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Rosaria Maddalena Ruggeri, cm1ydWdnZXJpQHVuaW1lLml0